Читать книгу Metabolic Syndrome Consequent to Endocrine Disorders - Группа авторов - Страница 5

Оглавление

Frontiers of Hormone Research

Founded 1972 by Tj.B. van Wimersma Greidanus, Utrecht

Continued by Ashley B. Grossman, Oxford (1996–2013)

_______________________Vera Popovic, MD, PhDMedical FacultyUniversity of BelgradeDr. Subotica 1311000 Belgrade (Serbia) _______________________Marta Korbonits, MD, PhDWilliam Harvey Research InstituteBarts and the London School of MedicineQueen Mary University of LondonCharterhouse SquareLondon EC1M 6BQ (UK)

Library of Congress Cataloging-in-Publication Data

Names: Popovic, Vera, editor. | Korbonits, Marta, editor.

Title: Metabolic syndrome consequent to endocrine disorders / volume editors, Vera Popovic, Marta Korbonits.

Other titles: Frontiers of hormone research ; v. 49. 0301-3073

Description: Basel ; New York : Karger, 2018. | Series: Frontiers of hormone research, ISSN 0301-3073 ; vol. 49 | Includes bibliographical references and indexes.

Identifiers: LCCN 2018003206| ISBN 9783318063349 (hard cover : alk. paper) | ISBN 9783318063356 (electronic version)

Subjects: | MESH: Endocrine System Diseases--complications | Metabolic Syndrome--etiology

Classification: LCC RC662.4 | NLM WK 140 | DDC 616.3/99--dc23 LC record available at

https://lccn.loc.gov/2018003206

Bibliographic Indices. This publication is listed in bibliographic services, including Current Contents® and PubMed/MEDLINE.

Disclaimer. The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publisher and the editor(s). The appearance of advertisements in the book is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Drug Dosage. The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.

All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.

© Copyright 2018 by S. Karger AG, P.O. Box, CH–4009 Basel (Switzerland)

www.karger.com

Printed on acid-free and non-aging paper (ISO 9706)

ISSN 0301–3073

e-ISSN 1662–3762

ISBN 978–3–318–06334–9

e-ISBN 978–3–318–06335–6

Metabolic Syndrome Consequent to Endocrine Disorders

Подняться наверх